IgA nephropathy-the case for a genetic basis becomes stronger

Nephrology Dialysis Transplantation

Volumn 25, Issue 2, 2010, Pages 336-338

  Kiryluk, Krzysztof ^a   Gharavi, Ali G ^a   Izzi, Claudia ^b   Scolari, Francesco ^b,c  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b SPEDALI CIVILI   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A1;

GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROCESSING;

GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A;

EID: 75649135278     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp593     Document Type: Note

References (28)

1. Hall YN, Fuentes EF, Chertow GM et al. Race/ethnicity and disease severity in IgA nephropathy. BMC Nephrol 2004; 5: 10
2. Hoy WE, Hughson MD, Smith SM et al. Mesangial proliferative glomerulonephritis in southwestern American Indians. Am J Kidney Dis 1993; 21: 486-496
3. Smith SM, Harford AM. IgA nephropathy in renal allografts: increased frequency in native American patients. Ren Fail 1995; 17: 449-456
4. Hughson MD, Megill DM, Smith SM et al. Mesangiopathic glomeru-lonephritis in Zuni (New Mexico) Indians. Arch Pathol Lab Med 1989; 113: 148-157
5. O'Connell PJ, Ibels LS, Thomas MA et al. Familial IgA nephropathy: a study of renal disease in an Australian aboriginal family. Aust NZ J Med 1987; 17: 27-33
6. Casiro OG, Stanwick RS, Walker RD. The prevalence of IgA nephropathy in Manitoba Native Indian children. Can J Public Health 1988; 79: 308-310
7. Johnston PA, Brown JS, Braumholtz DA et al. Clinico-pathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy. A report from the MRC Glomerulonephritis Registry. Q J Med 1992; 84: 619-627
8. Rambausek M, Hartz G, Waldherr R et al. Familial glomerulonephri-tis. Pediatr Nephrol (Berlin, Germany) 1987; 1: 416-418
9. Schena FP, Scivittaro V, Ranieri E et al. Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy. Clin Exp Immunol 1993; 92: 139-144
10. Julian BA, Quiggins PA, Thompson JSet al.Familial IgA nephropathy. Evidence of an inherited mechanism of disease. N Engl J Med 1985; 312: 202-208
11. Levy M. Familial cases ofBerger's disease and anaphylactoid purpura: more frequent than previously thought. Am J Med 1989; 87: 246-248
12. Scolari F, Amoroso A, Savoldi S et al. Familial clustering of IgA nephropathy: further evidence in an Italian population. Am J Kidney Dis 1999; 33: 857-865
13. Paterson AD, Liu XQ, Wang K et al. Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36. J Am Soc Nephrol 2007; 18: 2408-2415
14. Karnib HH, Sanna-Cherchi S, Zalloua PA et al. Characterization of a large Lebanese family segregating IgA nephropathy. Nephrol Dial Transplant 2007; 22: 772-777
15. Gharavi AG, Yan Y, Scolari F et al. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 2000; 26: 354-357
16. Bisceglia L, Cerullo G, Forabosco P et al. Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. Am J Hum Genet 2006; 79: 1130-1134
17. Cattran DC, Coppo R, Cook HT et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009
18. Beerman I, Novak J, Wyatt RJ et al. The genetics of IgA nephropathy. Nat Clin Pract Nephrol 2007; 3: 325-338
19. Tomana M, Novak J, Julian BA et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 1999; 104: 73-81
20. Smith AC, de Wolff JF, Molyneux K et al. O-glycosylation of serum IgD in IgA nephropathy. J Am Soc Nephrol 2006; 17: 1192-1199
21. Moldoveanu Z, Wyatt RJ, Lee JY et al. Patients with IgA nephropa-thy have increased serum galactose-deficient IgA1 levels. Kidney Int 2007; 71: 1148-1154
22. Gharavi AG, Moldoveanu Z, Wyatt RJ et al. Aberrant IgA1 glycosy-lation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 2008; 19: 1008-1014
23. Lin X, Ding J, Zhu L et al. Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy. Nephrol Dial Transplant 2009
24. Suzuki H, Fan R, Zhang Z et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 2009; 119: 1668-1677
25. Kathiresan S, Melander O, Guiducci C et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipopro-tein cholesterol or triglycerides in humans. Nat Genet 2008; 40: 189-197
26. Kathiresan S, Willer CJ, Peloso GM et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Gen 2009; 41: 56-65
27. Weidinger S, Gieger C, Rodriguez E et al. Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus. PLoS Genet 2008; 4: e1000166
28. Denham S, Koppelman GH, Blakey J et al. Meta-analysis of genome-wide linkage studies of asthma and related traits. Respir Res 2008; 9: 38